Právní předpis byl sestaven k datu 19.04.2025.
Zobrazené znění právního předpisu je účinné od 19.12.2012.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2013
420/2012 Sb.
420
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
xx xxx 22. listopadu 2012
x antigenním xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, zvláštní x xxxxxxxxx xxxxxxxx xxx xxx 2013
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 odst. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx zdraví x x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx antigenní xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2013:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx forma), virové xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (DTaPHibVHBIPV):
Xxxxxxxxx anatoxinum
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxxxxxx xxxxxxxxx externae proteinum
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx xxxxxxxxxx min.
Xxxxxxxxx xxxxxxxxx hepatitidis X xxxxxxxxxxxxxx
Virus poliomyelitidis xxxxxxxxxxx typus 1
Xxxxx xxxxxxxxxxxxxxx inactivatum xxxxx 2
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3
Xxxxxxxxxx Hib: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx b, Tetani xxxxxxxxxx
1x) očkovací xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu (XXxX):
Xxxxxxxxxxx anatoxinum ≥ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ≥ 40 xxxxxxxxxxxxx jednotek
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, nákazám xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
Xxxxxxxxxxx anatoxinum | xxx. 30 xxxxxxxxxxxxx xxxxxxxx |
Tetani anatoxinum | xxx. 40 xxxxxxxxxxxxx xxxxxxxx |
Xxxxxxxxx xxxxxxxxxx (XX) | 25 xxxxxxxxxx |
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) | 25 xxxxxxxxxx |
Xxxxxxxxxxx (69kD) | 8 xxxxxxxxxx |
Xxxxxxxxxxx xxxxxxxxxx X | 10 xxxxxxxxxx |
xxx xxxxxxxxx xxxxxxxx | 20-40 xxxxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxxx x xxxxxx - xxxxxxxxx:
Xxxxxxxxxx xxxxxxxxxxx purificatum ... xxx. 30 xxxxxxxxxxxxx xxxxxxxx
Anatoxinum tetani xxxxxxxxxxx ... min. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x:
1 xxxxx xxxxxxxxxxxxx xxxxxxx obsahuje: Xxxxxxxxxxxxxxx Xxx purificatum (10 mikrogramů) cum Xxxxxxxxx tetanico (30 xxxxxxxxxx).
1f) očkovací xxxxx proti tetanu:
Xxxxxx xxxxxxxxxx ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1g) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X x xxxxxx xxxxxxx:
Antigenum xxxxxxxxx hepatitidis X
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X x xxxxxxx xxxxxxx:
Antigenum xxxxxxxxx xxxxxxxxxxx X
1xx) xxxxxxxx xxxxx proti xxxxxxxxxx, příušnicím x xxxxxxxxx:
Morbillorum xxxxx xxxxxxxxxx (Schwarz) xxx. 103,0 xxxxxxxx dávka xxx buněčnou xxxxxxx50
Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) xxx. 103,7 infekční xxxxx xxx xxxxxxxx xxxxxxx50
Xxxxxxxx xxxxx attenuatum (Xxxxxx RA 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx50
1x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx formě:
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Xxxxxxx) ... 40 xxxxxxxxxxx X xxxxxxxx*
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ... 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ... 32 xxxxxxxxxxx X xxxxxxxx*
* xxxx xxxxxxxx ekvivalentních xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx formuli:
Polysaccharidum Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10X, 11X, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23X, 33F ... 25 mikrogramů x xxxxxxx xxxxxxxx
1k) xxxxxxxx látka konjugovaná xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 4
Xxxxxxxxxxxxx polysaccharidum sérotypus 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6A
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6B
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 9V
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 14
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19A
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 23X
1la) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxxxxxxxx xxxxxxxxxx | xx xxxx xxx 2 mezinárodní xxxxxxxx |
Xxxxxx xxxxxxxxxx | xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx |
Pertusové xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx | 8 xxxxxxxxxx |
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx | 8 xxxxxxxxxx |
Xxxxxxxxx | 2,5 xxxxxxxxxx |
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx) | 40 X xxxxxxxx antigenu |
xxxxx 2 (xxxx XXX-1) | 8 X xxxxxxxx xxxxxxxx |
xxxxx 3 (kmen Xxxxxxx) | 32 X xxxxxxxx xxxxxxxx |
NEBO
1lb) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Difterický xxxxxx | xxxx xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Lf) |
Xxxxxxxxx xxxxxx | xxxx xxxx rovno 20 xxxxxxxxxxxxx jednotek (5 Xx) |
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx toxoid | 2,5 xxxxxxxxxx |
Xxxxxxxxxxxx xxxxxxxxxxxx | 5 xxxxxxxxxx |
Xxxxxxx xxxx 2+3 | 5 xxxxxxxxxx |
Xxxxxxxxx | 3 xxxxxxxxxx |
Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) | 40 xxxxxxxxxxx X xxxxxxxx |
Virus poliomyelitis xxxx 2 (xxxxxxxxxxxx) | 8 antigenních X xxxxxxxx |
Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) | 32 xxxxxxxxxxx D xxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx tuberkulóze:
Xxxxxxxx Calmette Xxxxxx (xxxxxxxxxx) 100&xxxx;000 - 300&xxxx;000 V.U.*
(xxxx Xxxxxxxxxx 1331)
*X.X. = živé xxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B biosyntheticum 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (XXX) 50 xxxxxxxxxx v 1 xxxxx
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxx xxxxxxxx
2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx
Xxxxx xxxxxx xxxxxxxxxxx (xxxx Xxxxxx xxxxxx XX/XX 38&xxxx;1503-3X více xxxx rovno 2,5 xxxxxxxxxxxxx jednotek v 1 xxxxx (0,5 xx)
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx mimořádná očkování
3x) očkovací látka xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:
Hepatitis X xxxxx xxxxxxxxxxx
3x) očkovací xxxxx xxxxx xxxxxx hepatitidě X xx xxxxxxx xxx děti:
Virus xxxxxxxxx X xxxxxxxxxxx
Xxxxxxx:
xxx. XXXx. Xxxxx, XXx., x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 420/2012 Sb. xxxxx xxxxxxxxx xxxx 19.12.2012.
Xx xxx xxxxxxxx právní xxxxxxx xxxxx xxxxx či xxxxxxxxx.
Znění xxxxxxxxxxxx xxxxxxxx norem xxxxxx právních předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx derogační xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.